Germany
· Delayed Price · Currency is EUR Egetis Therapeutics AB Statistics
Total Valuation
BST:P0F has a market cap or net worth of EUR 210.61 million. The enterprise value is 198.57 million.
| Market Cap | 210.61M |
| Enterprise Value | 198.57M |
Important Dates
The next confirmed earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 395.16M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +20.10% |
| Shares Change (QoQ) | +8.45% |
| Owned by Insiders (%) | 11.28% |
| Owned by Institutions (%) | 29.82% |
| Float | 222.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.07 |
| PS Ratio | 36.53 |
| PB Ratio | 6.73 |
| P/TBV Ratio | 6.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.27 |
| EV / Sales | 34.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.05 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.92 |
Financial Efficiency
Return on equity (ROE) is -82.37% and return on invested capital (ROIC) is -39.91%.
| Return on Equity (ROE) | -82.37% |
| Return on Assets (ROA) | -28.82% |
| Return on Invested Capital (ROIC) | -39.91% |
| Return on Capital Employed (ROCE) | -82.87% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 137,284 |
| Profits Per Employee | -753,523 |
| Employee Count | 42 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 30.30 |
Taxes
In the past 12 months, BST:P0F has paid 36,961 in taxes.
| Income Tax | 36,961 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.69% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -16.69% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.50 |
| Relative Strength Index (RSI) | 56.00 |
| Average Volume (20 Days) | 1,086 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BST:P0F had revenue of EUR 5.77 million and -31.65 million in losses. Loss per share was -0.09.
| Revenue | 5.77M |
| Gross Profit | 1.15M |
| Operating Income | -30.49M |
| Pretax Income | -31.61M |
| Net Income | -31.65M |
| EBITDA | -30.36M |
| EBIT | -30.49M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 19.94 million in cash and 7.85 million in debt, giving a net cash position of 12.09 million.
| Cash & Cash Equivalents | 19.94M |
| Total Debt | 7.85M |
| Net Cash | 12.09M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 31.30M |
| Book Value Per Share | 0.08 |
| Working Capital | 1.17M |
Cash Flow
| Operating Cash Flow | -24.67M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 128,938 |
| Net Borrowing | -2.94M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 19.87% |
| Operating Margin | -528.85% |
| Pretax Margin | -548.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BST:P0F does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.10% |
| Shareholder Yield | -20.10% |
| Earnings Yield | -15.03% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BST:P0F has an Altman Z-Score of -2.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.19 |
| Piotroski F-Score | 3 |